Background: Solar urticaria (SU) is a rare chronic inducible urticaria triggered via uncharacterized chromophores. We detail responses of a large patient series to monochromator phototesting and broadband ultraviolet radiation (UVR); relationship to life quality is explored.
| INTRODUC TI ON
Solar urticaria (SU) is a rare physical urticaria characterized by rapid onset of pruritus, erythemal flare and wheal formation following exposure to non-ionising radiation. The wavelengths triggering the reaction, that is, the action spectrum, can include ultraviolet (UV) B, UVA and visible light. [1] [2] [3] It is hypothesized that the provoking radiation reacts with a chromophore to form a photoallergen, which triggers IgEmediated mast cell degranulation and release of histamine, accompanied by enhanced synthesis of vasoactive and pro-inflammatory mediators including arachidonic acid metabolites, cytokines and chemokines. 4, 5 Involvement of cutaneous nerves produces itch and release of neuropeptides which may assist recruitment of 
O R I G I N A L A R T I C L E
Solar urticaria in 145 patients: Assessment of action spectra and impact on quality of life in adults and children mast cells and induction of erythemal flare. 6, 7 Despite preliminary work implicating differently sized chromophores in ultraviolet radiation (UVR) and visible light triggered SU, 8 their exact nature remains unknown. 9 Patients with SU can suffer disabling symptoms, usually occurring within a few minutes of sunlight exposure, and causing significant impact on their lives. A multicentre postal questionnaire study found that of 48 adult patients, one-third had a Dermatology Life Quality Index (DLQI) of >10, signifying a very large impact on their lives. 10 First-line management of SU comprises photoprotective measures and oral antihistamines. However, the efficacy of antihistamines is variable, with only 35% of 34 patients reported to benefit, 1 while some improvement of symptoms was seen in 75% of 29 patients. 2 Similarly, the efficacy of photoprotection is variable, ranging from 30% reporting a good response to "external photoprotection" 2 to 68% reporting sunscreens to be of some benefit. 1 Phototherapy has been reported in limited cases, with benefit seen through UVA therapy in 3  11 and   2 12 patients, and in 36.2% of 47 patients, 2 while PUVA 13 successfully treated four cases of SU, and UVB provided some benefit for 85% of 39 patients. 14 Plasmapheresis, which is difficult to access, and intravenous immunoglobulins sourced from pooled human plasma, have also been used, 15, 16 while more recently a good response has been reported in a proportion of SU patients treated with anti-IgE monoclonal antibody. 17 Data contributing to a better understanding of the challenges facing SU patients may assist future developments in their management.
We reviewed a large cohort (n = 145) of adult and child patients diagnosed with SU at a specialist photoinvestigation centre. Our principal objective was to examine the action spectrum of the condition; additionally, we assessed impact of SU on quality of life in a subset (n = 62) of patients and explored for a relationship to SU provocation. 
| MATERIAL S AND ME THODS

| Subjects
| Photoinvestigation
Monochromator phototesting: The skin of the mid-back was exposed to narrow wavebands of radiation to determine the wavelengths of sensitivity and thresholds for provocation of the condition, as previously described. 18 In brief, patients were exposed to narrowband 19 and sunscreen products while prior to 2009, the photopatch series comprised 10 agents: 9 organic UV filters, and sunscreen products.
Duplicate patches were applied (day 1) to skin of the mid-back for 24 hours following which one set was irradiated (day 2) with broadband UVA (320-400 nm; UVAL 801, Herbert Waldmann GmbH & Co. KG, Villingen-Schwenningen, Germany). Readings were taken at 24 hours and 48 hours post-UVR (days 3, 4) to examine for a crescendo response, using the International Contact Dermatitis
Research Group (ICDRG) grading.
20
Laboratory tests: These included plasma and urine porphyrin scan, and serum autoantibody screen, which were performed in all patients.
| Quality of life evaluation
The DLQI questionnaire 21 was completed by patients from January 2011 onwards to assess the impact of SU on quality of life both in the past week and past year. 10 The questionnaire comprises 10 questions relating to pruritus (Q1), embarrassment (Q2), shopping/ gardening (Q3), clothing (Q4), social and leisure activities (Q5), sport (Q6), working or studying (Q7), friendships (Q8), sexual difficulties (Q9) and impact of treatment (Q10). Each question is answered by "not at all," "a little," "a lot" or "very much." The score for each question ranges from 0-3 making a maximum score of 30, with higher scores equating to greater impairment, that is, score of >10 is very large impact, >20 is extremely large impact. The childhood dermatology life quality index (CDLQI) was used in those aged ≤18 years (text version 11-17 years 22 ; cartoon version ≤10 years 23 ).
| Statistical analysis
Values are expressed as mean ± SEM. Data were analysed using ANOVA and Pearson's correlation (r). Statistical significance was accepted at the P < .05 level (Stats Direct Ltd, Altrincham, UK).
| RE SULTS
| Subject demographics
In total, 2318 patients underwent photoinvestigation at the Photobiology Unit over this period; of these 145 (6.2%) patients were diagnosed to have SU (100 female; mean age 35.8, range 3-69 years). 
| Clinical features
With regard to experience in daily life, the following relate to the n = 118-126 patients addressing each individual aspect: 80.1% patients reported that less than 30 minutes of sunlight exposure triggered their condition; 82.5% reported their rash was triggered through window glass; a minority of patients (21%) perceived an increase in tolerance as the summer progressed; facial involvement was reported in 78.8% of patients. Of 97 (66.8%) patients who used sunscreen 43 (44.3%) reported some benefit and 29 (29.9%) no benefit.
In terms of seasons of the year affected, of the n = 145 patients:
9% were affected during 1 season, that is, summer only; 6.2% were affected during two seasons; 15.9% were affected in three seasons;
and the majority (60%) were affected all year round; this information was uncertain in 9% patients.
| Phototesting
Of the 145 patients, the majority (74.5%) had urticarial, that is, wheal and flare responses, provoked on phototesting, whereas the remain- In all, 84 (57.9%) patients were provoked by monochromator phototesting. Amongst the 18 children, 6 (33%) were provoked by F I G U R E 1 Wavelengths at which urticarial responses were observed in solar urticaria (SU) patients provoked by monochromator phototesting, shown for (A) the current study, n = 145 (B) the collation of SU patient series reported in the literature and this study, as detailed in Table 1 . Data shown are % patients responding to a given waveband TA B L E 1 Demographic data corresponding to action spectra in Figure 1 (B) Figure 1A shows the frequency of reactions by wavelength, with the most frequent responses occurring at 370 and 400 nm.
Overall, 65.6% patients were provoked on broadband UVR testing.
Broadband UVA testing (n = 142 patients) provoked wheal and flare response in 85 (59.8%) patients. Of the 17 children tested to broadband UVA, 6 (35.2%) were provoked. A subset (n = 63) of patients underwent additional SSR testing of whom 56 (88.9%) were provoked.
Testing using a combination of monochromator phototesting and broadband UVR sources successfully provoked urticarial responses in 108 of 145 patients; had either alone been used the response rate would have been lower (Figure 2) . If the broadband UVA source alone had been used, 16 patients who were broadband UVA negative but monochromator positive would have been missed (Figure 2A) . Similarly, the use of the solar simulator alone would have missed three monochromator-positive patients ( Figure 2B ). Of the 61 patients who were monochromator negative, 24 were provoked by broadband UVR ( Figure 2C ) highlighting the importance of using both narrow and broad emission sources. No SSR provocation negative patients were successfully provoked by broadband
Comparison of provocation responses to broadband and monochromator phototest sources. Numbers of patients with positive monochromator response who (A) tested negative to broadband UVA and vice versa and (B) tested negative to solar simulated radiation (SSR) and vice versa. (C) tested negative to monochromator phototesting and vice versa (D) solar simulator positive patients testing negative to broadband UVA and vice versa UVA, whereas 8 broadband UVA provocation negative patients were positively provoked by SSR ( Figure 2D ).
| Photopatch testing
Four patients had five positive photopatch tests, whereas three patients had three positive responses to both the photopatch test and its control patch test, indicating a positive patch test. The positive photopatch responses were to patients own sunscreen products and, in one case, topical ketoprofen. The agent responsible in the patients' own sunscreen products was not identified although it is noted that the products contained additional UV filters that did not form part of the test series at that time. Patch-positive responses were all to patients own sunscreen products.
| DLQI
In all, 62 (78%) SU patients since 2011 completed the DLQI questionnaires; these gave a mean ± SEM DLQI score of 11. Responses to the individual questions of the DLQI questionnaire are shown in Figure 3 . The greatest impact was on choice of clothing, with mean score 2.1 ± 0.1 and 2.2 ± 0.1 (past week and year, respectively) and the lowest impact was for sexual difficulties (0.3 ± 0.1 and 0.3 ± 0.1, past week and year, respectively).
| D ISCUSS I ON
In this large series of patients with the orphan disorder SU, the majority, almost three-quarters (74.5%), were positively provoked by phototesting. The most frequent wavelengths provoking urticarial responses were in the UVA, and UVA plus visible light, wavebands, with few patients provoked by UVB. Our experience highlights the increased positive photoprovocation yield when using both broadband (65.6% patients provoked if used alone) and monochromator (57.9% patients provoked if used alone) sources during investigation of patients with suspected SU, with ~one-quarter patients who were broadband UVR positive found to be narrowband UVR negative, and vice-versa. Comparing broadband UVR sources, photoprovocation was notably more successful with solar simulated UVR than with broadband UVA.
Monochromator phototesting highlighted the role of longer wavelength UVA and shorter wavelength visible light in provoking urticarial responses, with the most frequent responses seen at 370
and 400 nm. The key role these longer wavelengths play in SU is consistent with our review of published action spectra derived from monochromator phototesting, as summarized ( Figure 1B , Table 1 ).
In their report of 87 patients in whom SU was demonstrable on phototesting, Beattie et al 1 also highlighted the involvement of 430 and 460 nm. In the examination of potential chromophores responsible, 24 those absorbing at the longer UVA/visible border warrant particular attention.
Longer wavelength UVA and visible light are present in substantial amounts in ambient radiation in winter as well as summer, and thus, while the severity of expression tends to be worse in the summer months, patients provoked by these wavelengths may manifest their condition in a year-round manner. This is consistent with our data showing a majority of 60% of SU patients were affected all year round while 31.1% were affected seasonally.
Additionally, topical sunscreen efficacy is reduced at these longer wavelengths, with 29.9% of responding patients reporting no benefit, which may contribute to the large impact SU has on the quality of life.
Our DLQI data highlight the impact SU can have on QoL with 56.1% and 69.8% of patients (past week and year, respectively) experiencing a very large (score >10) and 19.3% and 30.2% an extremely F I G U R E 3 Responses to individual questions of the dermatology life quality index (DLQI) questionnaire, assessing impact over the past week and past year. Data are mean ±SEM large (score >20) impact. 25 Subdomain scores highlight the impact on daily activities such as "shopping" and "clothing choices" with a mean of 1.8 (SD 1.1) when compared to chronic spontaneous urticaria (mean ± SD, 1.3 ± 0.9). 26 The impact on life quality of this rare condition has not been extensively reported. A UK multicentre study of the DLQI of n = 48 adult SU patients was reported in 2008, based on questionnaires mailed to previously photoinvestigated patients. 10 We found a higher median DLQI over the past week of 11 compared with 9 in the multicentre study, and DLQI over the past year of 12 compared with 10. This might reflect differences in study design, with our DLQI data consistently collected from patients at their investigation visit; patients were given explanation if required although completed the forms independently. Thus, 78% patients Strengths of this study include the detailed clinical and phototesting data obtained in a large series of this rare disorder, in both adults and children. While the study is retrospective, and DLQI questionnaires were only commenced in 2011, detailed and standardized clinical and photobiological proforma were used in all patients. The impact of the disorder on QoL was assessed using a validated tool for dermatology, the DLQI questionnaire; however, this is validated for assessment of impact on QoL over the past week, and while it has been applied to assess impact over the past year including in a multicentre study, 10 its use in this manner awaits validation.
In conclusion, this largest reported study of monochromator phototesting in SU has confirmed the variable action spectrum of 
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